August 15th 2025
Daria Lewis, FNP, DNP, emphasizes the importance of patient connection and collaboration in managing bipolar disorder medications for improved daily functioning.
July 25th 2025
Psychotherapy faces skepticism in psychiatry, yet it remains vital for understanding patients' narratives and enhancing therapeutic relationships.
SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea
View More
Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment
View More
PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia
View More
Southern Florida Psychiatry Conference
November 21-22, 2025
Register Now!
Managing Postpartum Depression in Clinical Practice
August 15th 2025Experts discuss that after a positive screen for perinatal mood or anxiety disorders, timely and compassionate intervention—through trusted resources like Postpartum Support International, thoughtful medication and therapy options, and patient-centered education that addresses stigma and supports shared decision-making—is key to achieving meaningful recovery and improved parent-infant outcomes.
Improving Patient Communication in Postpartum Depression
August 15th 2025Experts discuss that reducing stigma, normalizing mental health conversations from the first prenatal visit, expanding access through integrated and virtual care, and addressing systemic barriers through education, collaboration, and policy reform are all critical strategies for improving the detection and treatment of perinatal mood and anxiety disorders.
Evolving Schizophrenia Treatment Paradigm
August 11th 2025Panelists discuss how xanomeline/trospium chloride should be positioned as a first-line treatment option rather than waiting for treatment failures, given its superior effect size, comprehensive symptom coverage, and favorable tolerability profile compared with that of traditional antipsychotics.
Recommendations for Switching to Xanomeline/Trospium Chloride for Patients With Schizophrenia
August 11th 2025Panelists discuss how switching patients to xanomeline/trospium chloride requires different cross-titration strategies depending on whether patients are on “done” medications versus “pines” medications, with special attention to anticholinergic effects when transitioning from sedating antipsychotics.